| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |